Key result
Class III myosins, specifically MYO3A and MYO3B, play a crucial role in regulating stereocilia lengths in inner ear hair cells, and mutations in these proteins are associated with delayed onset hearing loss.
Understanding the role of class III myosins in maintaining stereocilia length may lead to novel therapeutic strategies for hearing loss due to stereocilia degeneration.
Answers are grounded in this paper and cite their sources.
May guide genetic screening in progressive hearing loss; leaves open myosin-targeted therapies pending human validation.
Cytoskeletal motors produce force and motion using the energy from ATP hydrolysis and function in a variety of mechanical roles in cells including muscle contraction, cargo transport, and cell division. Actin-based myosin motors have been shown to play crucial roles in the development and function of the stereocilia of auditory and vestibular inner ear hair cells. Hair cells can contain hundreds of stereocilia, which rely on myosin motors to elongate, organize, and stabilize their structure. Mutations in many stereocilia-associated myosins have been shown to cause hearing loss in both humans and animal models suggesting that each myosin isoform has a specific function in these unique parallel actin bundle-based protrusions. Here we review what is known about the classes of myosins that function in the stereocilia, with a special focus on class III myosins that harbor point mutations associated with delayed onset hearing loss. Much has been learned about the role of the two class III myosin isoforms, MYO3A and MYO3B, in maintaining the precise stereocilia lengths required for normal hearing. We propose a model for how class III myosins play a key role in regulating stereocilia lengths and demonstrate how their motor and regulatory properties are particularly well suited for this function. We conclude that ongoing studies on class III myosins and other stereocilia-associated myosins are extremely important and may lead to novel therapeutic strategies for the treatment of hearing loss due to stereocilia degeneration.
No takes yet. Share an insight, caveat, or question.
Cirilo et al. (2021) conducted a review in Hearing loss. Class III Myosins was evaluated. Class III myosins, specifically MYO3A and MYO3B, play a crucial role in regulating stereocilia lengths in inner ear hair cells, and mutations in these proteins are associated with delayed onset hearing loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: